COVID-19 Greatly Increases Mortality Risk for Schizophrenia Patients, Research Shows

Researchers in the United States and Israel strongly urge that patients with schizophrenia be prioritized for receiving the COVID-19 vaccine, as studies show these patients are at significantly higher risk for hospitalization and death.